OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Merck & CO INC MERCK & CO ORD (CD.../  US58933Y1055  /

London Domestic
5/15/2024  4:45:21 PM Chg. - Volume Bid4:03:31 PM Ask4:03:28 PM Market Capitalization Dividend Y. P/E Ratio
130.4000USD - 62,536
Turnover: -		 127.8000Bid Size: 300 134.6000Ask Size: 300 332.91 bill.USD 2.25% 938.86
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
TeleTrader 2/1 Merck's Q4 sales up 6% to $14.6B
TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 10/26/2023 Merck's Q3 sales up 7% to $16B
TeleTrader 10/20/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs
TeleTrader 6/6/2023 WH defends Medicare over Merck lawsuit
TeleTrader 6/6/2023 Merck sues US gov't over drug price negotiations
TeleTrader 4/27/2023 Merck's Q1 sales land at $14.5B, down 9%
TeleTrader 4/16/2023 Merck reportedly in talks to buy Prometheus Biosciences
TeleTrader 2/24/2023 EU regulator recommends against Merck's COVID drug
TeleTrader 2/2/2023 Merck posts Q4 sales up 2% to $13.8B
TeleTrader 1/13/2023 J&J reportedly cuts COVID vaccine production
TeleTrader 12/30/2022 China greenlights import of Merck's COVID pill
TeleTrader 12/13/2022 Moderna soars 22% on cancer vaccine breakthrough
TeleTrader 12/13/2022 Moderna soars 8% premarket on cancer vaccine results
TeleTrader 12/12/2022 Merck starts tender offer for Imago BioSciences at $36 per share
TeleTrader 10/27/2022 Merck: Q3 sales increase 14% to $14.96B
TeleTrader 7/28/2022 Merck: EPS more than triples to $1.55 in Q2
TeleTrader 6/17/2022 Merck discussing buying Seagen for $28B - report
TeleTrader 4/28/2022 Merck's Q1 EPS up 57% to $1.70
TeleTrader 3/16/2022 Merck halts new Russia investments
TeleTrader 2/3/2022 Merck's sales up by 24% to $13.52 billion in Q4
TeleTrader 1/18/2022 Merck, Ridgeback to supply 3 million courses of molnupiravir
GlobeNewswire 1/11/2022 Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
TeleTrader 12/28/2021 India approves use of Merck's COVID-19 pill